Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03891160 · ClinicalTrials.gov registry record · NA
Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment
A NA study of Congenital Heart Disease, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 5
- Study locations
NCT03891160: Recruiting NA study of Congenital Heart Disease, sponsored by Columbia University.
NCT03891160 is a NA study of Congenital Heart Disease that is actively recruiting participants, run by Columbia University. The registered enrollment target is 36 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (92% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03891160, a NA study of Congenital Heart Disease, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this research study is to look at the advantages of using a 3D printed heart model for surgical planning in children who have been diagnosed with Congenital Heart Disease (CHD) and clinical heart failure and will undergo a ventricular assist device (VAD) placement. The investigators want to study the correlation of having a 3D printed model with improvement in patient outcomes and compare those with patients who have had a VAD placement without a 3D model.
Primary Outcome
Change in survey responses regarding clarity of VAD or cannula site placement.
Conditions Studied
Interventions
- OTHER 3D model of heart
Study Locations (5)
New York
- Columbia University - New York
- Weill Cornell - New York
Florida
- University of Florida - Gainesville
Georgia
- Children's Healthcare of Atlanta - Atlanta
Illinois
- Lurie Children's Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2020-01-22 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What NCT03891160 shows while recruiting
NCT03891160 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which 3D model of heart is the first listed.
NCT03891160 lists 5 locations in 4 states (New York, Florida, Georgia).
Frequently Asked Questions
What is clinical trial NCT03891160 about?
NCT03891160 is a clinical study titled "Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment". The purpose of this research study is to look at the advantages of using a 3D printed heart model for surgical planning in children who have been diagnosed with Congenital Heart Disease (CHD) and clinical heart failure and will undergo a ventricular assist device (VAD) placement. The investigators w...
What is the current status of trial NCT03891160?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2020-01-22. Estimated completion is 2027-07-31.
What conditions does trial NCT03891160 study?
This clinical trial studies the following conditions: Congenital Heart Disease.
What interventions are being tested in trial NCT03891160?
The interventions under investigation include: 3D model of heart (OTHER).
Who is sponsoring clinical trial NCT03891160?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03891160 being conducted?
This trial has 5 study locations across Florida, Georgia, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03891160's enrollment target sits among peer trials
36 52nd of 63 higher than 11 of 63 other Congenital Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fontan Fitness Trial
RECRUITING · NA
-
Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
RECRUITING · NA
-
The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
RECRUITING · NA
-
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
RECRUITING · NA
-
A Study of Hemodynamic Cardiopulmonary Exercise for CHD
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI